Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Doripenem (500mg) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
500mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dorityle 500 Injection contains Doripenem (500mg), a broad-spectrum carbapenem antibiotic used to treat serious bacterial infections. Doripenem works by inhibiting bacterial cell wall synthesis, which effectively kills bacteria. It is especially useful against multidrug-resistant Gram-negative and Gram-positive bacteria, including those causing hospital-acquired infections.
It helps in the treatment of complicated infections such as urinary tract infections, intra-abdominal infections, pneumonia (including ventilator-associated pneumonia), skin and soft tissue infections, and bloodstream infections, particularly in critically ill or hospitalized patients.
Common side effects include nausea, vomiting, diarrhea, headache, rash, or pain at the injection site. Rarely, it may cause allergic reactions, seizures (especially in patients with kidney problems), or liver and kidney function changes.
Used for moderate to severe bacterial infections involving the urinary tract, lungs, abdomen, bloodstream, and skin. It is often prescribed when infections are caused by resistant organisms or when first-line antibiotics are ineffective.
Administer only under the supervision of a healthcare professional. Inform your doctor of any history of kidney disease, seizures, or allergies to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems). Complete the full prescribed course to prevent resistance.
Store below 25°C in a dry place, protected from light. Reconstituted solution should be used immediately or as advised by a medical professional. Keep out of reach of children.
Composition : Levofloxacin 500mg Infusion
Composition : Linezolid Intravenous Infusion I.P. 2mg Infusion
Composition : Moxifloxacin IP 400 mg + Mannitol IP 5.0% w/v Infusuion
Composition : Ceftriaxone (125mg) Injection
Composition : Azithromycin (500mg) Injection
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Colistimethate Sodium (1Million IU)
Composition : Clindamycin (300mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Doripenem 500mg Injection is a high-end carbapenem antibiotic used for severe and resistant bacterial infections, making it a strong specialty product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent hospital demand in ICU and critical care settings for complicated infections like pneumonia, intra-abdominal infections, complicated UTI, and multidrug-resistant (MDR) bacterial infections. It is strictly used under specialist supervision in hospitals.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Doripenem 500mg Injection (1 vial) with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high-value institutional sales, steady ICU-based demand, and long-term hospital procurement cycles in the critical care antibiotic segment when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this critical antibiotic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.